MARC record from Internet Archive

LEADER: 05422cam 2201033 a 4500
001 ocm17234197
003 OCoLC
005 20210108170948.0
008 871125s1988 enk b 001 0 eng
010 $a 87034203
040 $aDNLM/DLC$beng$cDLC$dNLM$dMUQ$dNLGGC$dBTCTA$dYDXCP$dBAKER$dOCLCG$dUKM$dGEBAY$dOCLCQ$dPBU$dGBVCP$dOCLCO$dOCLCF$dOCLCQ$dCOH$dOCLCQ$dOCLCO$dOCLCA$dIDU$dOCLCA$dCASUM$dOCLCO$dMST$dOCLCA$dUKBTH$dOCLCA$dIL4J6
015 $aGB8807661$2bnb
016 7 $a8712184$2DNLM
019 $a17229646$a17439771$a1022734106$a1167049804
020 $a0521340233
020 $a9780521340236
035 $a(OCoLC)17234197$z(OCoLC)17229646$z(OCoLC)17439771$z(OCoLC)1022734106$z(OCoLC)1167049804
043 $an-us---
050 00 $aRA418.5.M4$bD88 1988
060 00 $aW 50$bD981w 1988
080 0 $a610.01
082 00 $a362.1$219
084 $a44.01$2bcl
084 $a44.02$2bcl
100 1 $aDutton, Diana Barbara.
245 10 $aWorse than the disease :$bpitfalls of medical progress /$cDiana B. Dutton, with contributions by Thomas A. Preston, Nancy E. Pfund.
260 $aCambridge [England] ;$aNew York :$bCambridge University Press,$c1988.
300 $axvi, 528 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 383-511) and index.
505 0 $aIntroduction -- Where are we and how did we get there? -- DES and the elusive goal of drug safety -- The artificial heart / by Thomas A. Preston -- The swine flu immunization program -- Genetic engineering: science and social responsibility / by Diana B. Dutton and Nancy E. Pfund -- Risks and rights -- Compensating the injuries of medical innovation -- What is fair? Medical innovation and justice -- The role of the public -- What is possible? Toward medical progress in the public interest.
500 $aAPPE gift.$5InGrD
520 $aThis book examines four medical innovations that epitomize the pitfalls of progress: DES, a synthetic estrogen prescribed to millions of women to prevent miscarriages, which produced devastating side effects; the artificial heart; the 1976 swine flu immunization program; and genetic engineering. Dutton and the contributors trace the human choices that govern medical and scientific innovation and explore the political, economic, and social factors that influence those choices. In the process, they reveal a deep gulf between the priorities of medical innovation and the concerns of the general public. They then propose concrete policy changes to help bridge that gulf.
650 0 $aMedical innovations$xSocial aspects$vCase studies.
650 0 $aMedical innovations$xSocial aspects.
650 0 $aMedical innovations$xMoral and ethical aspects$vCase studies.
650 0 $aMedical innovations$xMoral and ethical aspects.
650 0 $aMedical innovations$xEconomic aspects$vCase studies.
650 0 $aMedical innovations$xEconomic aspects.
610 22 $aNational Institutes of Health (U.S.)
610 22 $aUnited States.$bFood and Drug Administration.
650 22 $aHuman Experimentation.$0https://id.nlm.nih.gov/mesh/D006805
650 22 $aTechnology Assessment, Biomedical.$0https://id.nlm.nih.gov/mesh/D013673
650 2 $aEthics, Medical.$0https://id.nlm.nih.gov/mesh/D004992
650 2 $aHealth Policy$xtrends.$0https://id.nlm.nih.gov/mesh/D006291Q000639
650 2 $aMedicine.$0https://id.nlm.nih.gov/mesh/D008511
651 2 $aUnited States.$0https://id.nlm.nih.gov/mesh/D014481
651 4 $aUnited States.
650 6 $aMédecine$xInnovations.
650 7 $aMedical innovations$xEconomic aspects.$2fast$0(OCoLC)fst01014184
650 7 $aMedical innovations$xMoral and ethical aspects.$2fast$0(OCoLC)fst01014190
650 7 $aMedical innovations$xSocial aspects.$2fast$0(OCoLC)fst01014193
650 7 $aMedizin$2gnd
650 7 $aInnovation$2gnd
650 7 $aSoziologie$2gnd
650 7 $aGeschichte$2gnd
650 7 $aWissenschaftlich-technischer Fortschritt$2gnd
650 7 $aMedizinische Ethik$2gnd
650 17 $aGeneeskunde.$2gtt
650 17 $aTechnische vernieuwing.$2gtt
650 17 $aOnderzoek.$2gtt
650 17 $aFouten.$2gtt
650 7 $aMedical innovations.$2nli
650 7 $aMedical innovations$xSocial aspects.$2nli
651 7 $aUSA.$2swd
653 $aMedicine$aInnovation$aSocial aspects
655 7 $aCase studies.$2fast$0(OCoLC)fst01423765
700 1 $aPreston, Thomas A.,$d1933-
700 1 $aPfund, Nancy E.
740 0 $aPitfalls of medical progress.
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/cam023/87034203.html
856 41 $3Table of contents$uhttp://www.gbv.de/dms/bs/toc/026117150.pdf
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/cam023/87034203.html
938 $aBaker & Taylor$bBKTY$c44.95$d44.95$i0521340233$n0001424631$sactive
938 $aBaker and Taylor$bBTCP$n87034203
938 $aYBP Library Services$bYANK$n458532
029 1 $aAU@$b000005646358
029 1 $aGBVCP$b026117150
029 1 $aGEBAY$b784456
029 1 $aHEBIS$b027920348
029 1 $aNLGGC$b043217915
029 1 $aNLM$b8712184
029 1 $aNZ1$b5012418
029 1 $aYDXCP$b458532
029 1 $aNZ1$b215839
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 627 OTHER HOLDINGS